。,才"
GSH
↓伽イ
Cys
yGlucys
GIU
亘一
■■
稿を終えるにあたり、終始ご懇切なるご指導とご鞭捷を賜りました、摂南大 学大学院薬学研究科薬物治療学研究室教授、前田定秋先生に心より厚く御礼申
し上げます。
また、本研究を進めるにあたり、直接ご指導戴きました摂南大学大学院薬学 研究科薬物治療学研究室准教授、吉岡靖啓先生に深謝致します。
また、本研究を進めるにあたり、ご討論、ご指導戴きました摂南大学大学院 薬学研究科薬物治療学研究室助教、山室晶子先生、同助教、石丸侑希先生に感 謝致します。
謝辞
社会メ、大学院進学を支援して下さいました、塚本有子薬剤部長を女台めとする 近江八幡市立総合医療センター薬剤部の皆様、職場の皆様に感謝致します。
最後に多大なるご協力とご援助戴きました、茂木俊樹修士、辻本理絵学士、
森下あみ学士、白數千春学士、生田恵梨子学士、根来亮介学士、平野優学士を 始めとする摂南大学薬学部薬物治療学研究室の皆様に感謝致します。
61
1. clarke, D. D. and sok010ff, L. circulation and energy metabolism of the brain.1n: siegel G,
Agranoff, B., Albers, R. W., et al, editors. Basic Neurochemistry:Molecular, ce11Ular, and Medical Aspects.6th ed. philadelphia, USA: Lippinc0廿・Raven;(1999). P.637‑669.2. Ma廿Son, M. P. and Magnus, T.(2006). Ageing. and neuronal vulnerability. Nat ReνⅣeurosci.,フ,
278‑94.
3. Kim, GH., Kim, J. E., Rhie, S. J. and Yoon, S.(2015). The Role of oxidative stress in Neurodegenerative Diseases.五χPⅣ'eurohi01.,24,325‑40.
4. Yamagata, T., satoh, T.,1Shika、va, Y., Nakatani, A., Yamada, M.,1keuchi, T. and Hata11aka, H.
(1999). Brain・derived neurotropic factor prevents superoxide anion・induced death ofpC12h ceⅡS Stably expressing TrkB receptor via modulation of reactive oxygen species.入leurosci Res.,35,
9‑17.
5.、刃ilson, J. X. a997). Antioxidant defense of the brain: a role for astrocytes. Cα11. j physi01.
,har111ac01.,75,1149‑1163.
6. Jermer, P. and ola110、V, C.W.(1996). oxidative stress a11d the pathogenesis ofparkinson's disease.
Neur010幻,.,47,(6 SUPP13):S161‑70.
フ. zhao, Y. and zhao, B.(2013) oxidative stress and the pathogenesis ofAlzheimer's disease.伍id Ued ce11ι011gev.,2013,316523.
8. Emerit, J., Edeas, M., arld Bricaire, F.(2004). Neurodegenerative diseases and oxidative stress.
召i01ア1ed円hα1ファ1αCother.,58,39‑46.
9. Radad, K., Rausch, W. D. and GiⅡe, G.(2006) Rotenone induces ceⅡ death in primary dopaminergic culture by increasing Ros production and inhibiting mitochondrialrespiration.
<leuroche111111t.,49,379‑86.
10. XU, P., wang, H. and Li z. Yang z.(2015). Triptolide attenuated injuw via inhibiting oxidative
Stress in amyloid・Beta25‑35・treated differentiated pC12 Ce11S.11. Lewere11Z, J. andMaher, P.(2015). chronicGlutamateToxicity in Neurodegenerative Diseases・whatis the Evidence? Fr011t<leurosci.,16,9.469.
12. Tsuchioka, M., Takebayashi, M., Hisaoka, K., Maeda, N. a11d Nakata, Y.(2008). serotonin (5・HT)induces glialce111ine・derived neurotrophic factor(GDNF) mRNA expression via the transactivation offibroblast groMh factorreceptor 2 (FGFR2)in rat C6 glioma ceⅡS. j
<leuroche111.,106,244‑57.
13. olsen, M. L., Khakh, B. S., skatchkov, S. N., zhou, M., and Lee, C.J.and Rouach, N.(2015).
Ne、v lnsights on Astrocyte lon channels: critical for Homeostasis and Neuron、Glia signaling.ノ'
Neurosci.,35,13827‑35.
引用文献
14. Gras, G., porcheray, F., samah, B. and Leone, C.(2006). The glutamate・glutamine cycle as an inducible, protective face ofmacrophage activation. jιeukoc Bi01.80,1067ーフ5.
15. Dringen, R. and HinHnger, J.(2003). Glutathione path、Nays in the brain. Bi01. che111.,384,
505・16.
16. Gabryel, B.and Trzeciak, H.1.(20OD. Role ofastrocytes in pathogenesis ofischemic brain injury. Neur010χ. Res.,3,205‑21.
17. Kwon, Y.W., Masutani, H., Nakamura, H.,1Shii, Y.arld Yodoi,J.(2003). Redox regulation ofce groMh a11d ce11 death., Bi01.che"1.384,991‑996.
18. Dringen, R.,(200の. Metabolism and functions ofglutathione in brain. pr0宮. Neurohl'01.,62,
649‑671.
19.0'DolmeⅡ, J., zeppenfeld, D., Mcconne11, E., pena, S. and Nedergaard, M.(2012).
Norepinephrine: aneuro modulator that boosts the function ofmultゆle ce11types to optimize CNs perf0姉飢Ce.入セ1ιroche1ア1.Res.,37,24962512.
20. Reyes, B. A., Heldt, N. A., Mackie, K. and van Bockstaele, E. J.(2015). ultrastructural evidence for synaptic contacts beNeen codical noradrenergic afferents and
endocalmabinoid・synthesizing post・synaptic neurons.Ⅳ'eurosciehce.,10,303:323‑37.
21. Fahrig,T. U993). Receptor subtype involved and mechanism ofnorepinephrine・induced Stimulation ofglutamate uptake into primary cultures ofrat brain astrocytes. Gh'α.,フ,212‑218.
22. Hajek,1., subbarao, K.V. and Hertz, L.(1996). Acute and chronic effects ofpotassium and noradrenalineonNa+,K+‑ATpase activity in cultured mouse neurons and astrocytes.
Neuroche111.111t.,28,335‑342.
23. Juric, D. M., Loncar, D. atld caman・Krzan, M.(2008). Noradrener8ic stimulation ofBDNF Synthesis in astrocytes: mediation via alphal・and beta1小eta2‑adrener8ic receptors.入leuroche111.
Iht.,52,297.306.
24. Elena, M. V., va11essa, K. H., Ann・charlotte, G., Mark, A. E. and Gary, A. J.(2012). Nor epinephrine in neurodegeneration: at coerulean target. j 冱Izheiplers Dis.,2, e114.
25. Ha、Nkes, C. H., DelTredici, K. and Braak, H.(2010). A timeline for parkinson's disease.
Park. Re1αt. Disord.,16,79‑84.
26. Marien, M.R., colpaeH, F. C. and Rosenquist, A. C.(2004). Noradrenergic mecha11isms in neurodegenerative diseases: a theory. BraiπRes. BraiπRes. Rev,45,38‑78.
27. Heneka, M. T., Ramanathan, M., Jacobs, A. H., Dumitrescu・ozimek, L., Bilkei.Gorzo, A., Debeir, T., sastre, M., GaⅡdiks, N., zimmer, A., Hoehn, M., Heiss,、入'. D., Klockgether, T. and Staufenbiel, M.,(2006). Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. j Ⅳ'eurosci.,26,1343・B54.
28. Marien, M., Briley, M. and colpaed, F. a993). Noradrenaline depletion exacerbates 入4PTP・induced striatal dopalnine loss in mice.三Ur. j phar111ac01.,236,487‑489.
63
29. Fomai, F., Alessandri, M.G., Tonacca, M. T., Bassi, L. and corsini, G. U. a997). Effects of noradrenergic lesions on MPTP介、,伊P+ kinetics and MPTP・induced nigrostriatal dopamine depletions. j phar111αC01五χP rher.,283,100‑フ.
30. Kim, R. H., sm北h, P. D., Aleyasin, H., Hayley, S., Mount, M. P., PO、¥na11, S., wakeham, A., YOU・Ten, A. J., Kalia, S. K., Home, P.,、Nesta、Nay, D., Lozano, A. M., Anismatl, H., park, D. S.
and Mak, T. W.,(2005). Hypersensitivity ofDJ・1・deficient mice t0 1・methyl・
4・phenyl‑1,2,3,6・tetrahydropyrindine (MPTP) and oxidative stress. proc.Ⅳαtl.冱Cad. sci. US冱., 102,5215‑20.
31. Hartl, D., schuldt, V., Forler, S., zabel, C., Klose, J.arld Rohe,M.(2012). presymptomatic alterations in energy metabolism and oxidative stress in the APP23 mouse model ofAlzheimer disease. j prote0111e Res.,11,3295‑3304.
32. Aoyama, K., watabe, M.and Nakaki, T.(2008). Regulation ofneuronal glutathione synthesis. j
Phar"1acolsci.108 227‑38.
33. Ra1血an, K.(2007). studies on free radicals, antioxidal)ts, and co・factors. clih.111terv.冱宮iπg.,2,
219‑236
34. Meister A. atld Anderson M. E.(1983). Glutathione. Armu. Rev. Biochem.,52,711‑60.
35. Drin8en, R., GU廿erer, J. M.and Hinlinger, J.(200の. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species.五Urj Biochepl.,267,4912.6.
36.圦la11g, X. F. and cynader, M. S.(2000). Astrocytes provide cysteine to neurons by releasing glutathione. jⅣ'eurochepl.,74,1434‑42.
37. Dringen, R. a11d Hinlinger, J.(2003). Glutathione path、Nays in the brain. Biolchepl.,384,
505‑16.
38. Dringen, R., Kussmaul, L., Gutterer, J. M., Hinlinger, J. a11d Hamprecht, B.(1999). The glutathione system ofperoxide detoxi金Cation is less ef負Cient in neurons than in astr081ial ce11S.J Neurochel?1.,72,2523‑30.
39. Liu, X., shibata, T., Hisaka, S., Kawai, Y. arld osawa, T.(2008). DHA Hydroperoxides as a Potentia11nducer ofNeuronal ceⅡ Death: a Mitochondrial Dysfunction・Mediated path、Nay. j Ch'π召ioche111 Ⅳ'ulr.,43,26・33.
40. Hedz. L., Lovatt, D., Goldman, SA. a11d Nedergaard, M.(201の. Adrenoceptors in brain: ce11Ular gene expression arld effects on astrocytic metabolism and [ca(2+)]i. Neuroche1111πt.,57,411‑20.
41. Tripathi, A., Gaponenko, V.and Majetschak, M.(2015). commercia11y available antibodies
directed against a・adrenergic receptor sub匂,,pes and other G protein・coupled receptors 、vith
acceptable selectivity in ao、N cytometry experiments. NaU11y11Sch1ア1iedeみerg'S冱rch pharl?1αC01, [Epub 血ead ofprint}42. catus, S. L., Gibbs, ME., sato, M., summers, R.J.and Hutchinson, DS.(2011). Role of β・adrenoceptors in glucose uptake in astrocytes using β・adrenoceptor hlockout mice. Brj Phar1ア1αC01.,162,1700‑15.
43. Yoshioka, Y., Kitao, T., Kishino, T., Yamamuro, A. and Maeda, S.(2006). Nitric oxide protects macrophages from hydrogen peroxide・induced apoptosis by inducing the formation ofcatalase. j 11?1111U1101.176,4675・4681.
44. steele, M. L., FUⅡer, S., patel, M., Kersaitis, C., ooi, L.and Mnnch, G.(20B). Effect ofNrn activators on release ofglutathione, cysteinylglycine and homocysteine by human U373 astroglial ceⅡS. Red0χβi01.,1,441‑5.
45.Mersmann, H. J.(1998). oveNiew of the effects of beta・adrenergic receptor agonists on animal groMh including mechanisms ofaction. j冱hi1↑1.sci.,76,160,172.
46. scarpace, P. J., Dove, J. and Matheny, M. a996). Effects of age on beta adrenergic subtype actlvatlon ofadenvlul cvclase ln bro、vn adlpose れSsue. proc soC 三χ" BI01、入イεd.,213 262‑フ 47. Mizuno K, Kanda Y, Kuroki Y,圦ノatanabe Y.(200の. The stimulation ofbeta(3)・adrenoceptor
Causes phosphorylation of extraceⅡUlar signal・regulated kinases l and 2 t11rough a G(S)・ but not G(i)・dependent pathway in 3T3・Ll adipoCⅥes.三Wjphar1πac01.,15,404a・2):63・8.
48. Dickinson, D. A.,11es, K. E., watatlabe, N.,1Wamoto, T., zhang, H., Krzywanski, DM., and Forman, H. J.(2002).4・hydroxynonenalinduceS 81Utamate cysteine ligase through JNK in HBEI Ce11S. Free Radic Biolued.,33,974.
49. Lee, Y. J., Karlg,1. J., Bunger, R. and Kang, Y. H.(2004). Enhanced survival effect ofpyruvate Conelates MAPK and NF・kappaB activation in hydrogen peroxide・treated human endothelial Ce11S. j冱Pplphysi01(1985).,96,793‑801.
50. chemogubova, E., camlon, B. and Bengtsson, T.(2004). NorepineP11rine increases glucose transport in bro、vn adipocytes via beta3・adrenoceptors t11rough a cAN伊, PKA, and PB・kinase・dependent pathway stimulating conventional and novel pKCS.三πdocrl'π0108y.,145,
269‑280.
51. C0Ⅱins, S.(2012).β・Adrenoceptor signaling Net、¥orks in AdゆOcytes for Recruiting Stored Fat and Energy Expenditure. Fr011t.Ξ11docrl'π01.,2,102.
52. wi11iams, N. G., zhong, H. arld Minneman, K. P.,(1998). Differential coupling of alphal・, alpha2・, and beta‑adrenergic receptors to mitogen・activated protein kinase path、vays and differentiation in tra船fected pC12 Ce11S. j Bi01. che抗.,273,24624.24632 (pubMed:9733758).
53. Kaya, A.1., onaran, H.0., ozcan, G., Ambrosio, C., costa, T., BaⅡi, S.and ugur,0.,(2012).
Ce11 Contact・dependent functional selectivity of β2・adrenergic receptor ligands in stimulating CAMp accumulation and extrace11Ular si8nal・regulated kinase phosphorylation. jBi01.che111.287,
6362.6374.
65
54. Yaniv, S. P., Lucki, A., Klein, E. and Ben・shachar, D.(2010). Dexamethasone enhances the norepineP11rine・induced ERWMAPK intrace11Ular pathway possibly via dysregulation ofthe alpha2・adrenergic receptor:implications for antidepressant drug mechanism ofaction.
三Ur.jce11Bi01.89,712‑722.
55. sugimoto, T., Morioka, N., sato, K., Hisaoka, K. and Nakata, Y.(20ID. Noradrenergic regulation of periodl expression in spinal astrocytes is involved in protein kinase A, C・Jun N・terminal kinase and extraceⅡUlar signal・regulated kinase activauon mediated by α1. and β2・adrenoceptors.Ⅳ'e1ιroscie11Ce.,185,1・13.
56. Akinaga, J., Lima, V., Kiguti, L. R., Hebeler・Barbosa, F., Alcantara、Hemandez, R., Garcia.sainz, J. A. and pupo, A. S.,(2013). Differential phosphorylation, desensitization, and intemalization of αIA・adrenoceptors activated by norepineP11rine atld oxymetazoline. U01.phar111αC01.,83,
870‑881.
57. Boblk, A.,campbe11, J. H.and Lmle, P. J. U984).Desensitization of the alpha l adrenoceptor System in vascular smooth muscle. Bioche111.pharP1αC01.,33,1143‑1145.
58. Eason, M. G.and Lig8ett, S. B.,(1992). subtype・selective desensitization of alpha 2・adrenergic receptors. Different mechanisms control short and long term agonist‑promoted desensitization of alpha 2CI0, alpha 2C4, a11d alpha 2C2. j 召i01. che1ア1.,267,25473‑25479.
59.011i・Lahdesmaki, T., Tiger, M., vainio, M., scheinin, M. and KaⅡio, J.(2004). Ligand・induced alpha2・adrenoceptor endocytosis: relationship to Gi protein activation.βioche111.召iophys. Res
C0111111U11.321,226‑233.
60. wang, Y., DeArcangelis, V., Gao, X., Ramani, B., Jung, Y. S. and xiang, Y.(2008).
Norepinephrine・ and epineP11rine・induced distinct beta2・adrenoceptor signaling is dictated by GRK2 Phosphowlation in cardiomyocytes. j Bi01. chel?1.,283,1799‑1807.
61. chaudhry, A. and Gratmeman, J. G.(1994).1nauence ofce11type upon the desensitization ofthe beta3・adrenergicreceptor. jphar111ac01.三χP. rher.,271,1253‑1258
62. Jockers, R., Dasilva, A., strosberg, A. D., Bouvier, M. and MaNⅡ0, S. a996). New molecular and stNctural determinants involved in beta 2・adrenergic receptor desensitization and Sequestration. Delineation using chimeric beta 3小eta 2・adrenergic receptors. j 召i01. che111.,271,
9355‑9362
63. Day, R. M., suzuki, Y. J., Lum, J. M.,圦小ite, A. C., Fanburg, B. L.(2002). Bleomycin Upregulates expression of gamma・glutamylcysteine synthetase in pulmonary artery endothelial Ce11S.冱1?1. j physi01.ιU11g ce11. U01. physi01.,282, LB49‑1357
64. Ka、Nakita, Y.,1kekita, M., Kurozumi, R., Kojima, S.(2003).1ncrease ofintrace11Ular glutathione by low・dose gamma・ray inadiation is mediated by transcription factor AP・1in RAW 264フ CeⅡS.
Bi01. phar/11.召U11.,26,19‑23.
65. Kurozumi, R. and Kojima, S.(2005).1ncrease of intrace11Ular glutathione by lo、V.1evel NO
mediated by transcription factor NF・kappaB in RAW 264.7 CeⅡS. Biochi111.Biophys., Acta 1744,
58‑67.
66. Gavrilyuk, V., De110RUSSO, C., Heneka, M. T., pe11igrino, D., weinberg, G.and Feinstein, D. L.
(2002). Norepinephrine increases l kappa B alpha expression in astrocytes. j 召i01. cheJπ.,27フ,
29662.29668.
67. Jhang, K. A., Lee, E.0., Kim, H. S. and chong, Y. H.(2014). Norepinephrine provides Short・term neuroprotection against Aβ1‑42 by reducing oxidative stress independent of Nrn activation.入leur06i01.冱giπ8.,35,2465‑2473.
68. Karin, M., a996). The regulation ofAP・1 activity by mitogen・activated protein kinases. philos.
Trans. R. SOC. Lond. BBi01. sci.,351,127・B4.
69. whitmarsh, A. J., Davis, R. J.(1996). Tra11Scription factor AP・1 regulation by mitogen・activated Protein kinase signaltransduction path、Nays. J. M01. Med.74,589‑607
70. Rathinam,ト,4. L.,▽,/atts, L. T., Narasimhan, M., Riar,<.K.,ト,1ahimainathan, L. and Henderson, G.1.(2012). Astrocyte mediated protection of fetal cerebral cortical neurons from rotenone and Paraquat.三πνir011. roxic01.円harl?1αC01.,33,353‑60.
71. canals, S., casarejos, M. J., Rodriguez・Martin, E., de Bernardo, S. and Mena, M. A.(20OD.
Neurotrophic and neurotoxic effects ofnitric oxide on fetal midbrain cultures. j /veuroche111.,76,
56‑68.
2土2早
72. Ben・Yoseph,0., Boxer, P.A. a11d ROSS, B. D. a996). Assessment of the role of the glutathione and pentose phosphate path、vays in the protection of primary cerebrocortical cultures from Oxidative stress. j Neuroche1ア1.,66,2329‑37.
73. Fuson, K. S., Mark, R. J., pane廿a, J. A. and May, P. C.(1999). characterization of LY231617 Protection a8ainst hydrogen peroxide toxicity. J. Neurochem.,72,1154‑60.
74. Brandmarm, M., Tulpule, K., schmidt, M. M. and Dringen, R.(2012). The antiretroviral protease inhibitors indinavir and nelfinavir stimulate Mrpl・mediated GSH export from cultured brain astrocytes. j Ⅳ'eurochepl.120,78・92.
75. cole, SP.(2014). MultidNg resistance protein l (MRPI, ABCCI), a "multitasking"
ATP・binding cassette (ABC)transporter. j Bi01. che1π.,289,30880・8.
76. H011rlholt, M. C. and Dringen, R.(2014). short time exposure to hydrogen peroxide induces Sustained glutathione export from cultured neurons. Free. Radic.召i01. ued.,70,33‑44.
フフ. Troadec, J.D., Marien, M., Darios, F., Hartmalm, A., Ruberg, M., colpaert, F. and Michel, P. P.
(20OD. Noradrenaline provides long・term protection to dopaminergic neurons by reducing Oxidative stress. J. Neurochem.,79,200‑10.
78. Huang, R. P., Fan, Y., Hossain, M.Z., peng, A., zeng, Z. L. and Boynton A. L.(1998).
Reversion of the neoplastic phenotype of human glioblastoma ce11S by connexin 43 (CX43).
Cα11Cer. Res.,58,5089‑96.
79.1ZZO, G., d'1Stria, M., Fenara, D., serino,1., AnieⅡ0, F. and Minucci, S.,(2006). cotmexin 43 expression in the testis ofthe frog Rana esculenta. zygote.,14,349‑57.
80. Falm, S. and cohen, G.(1992). The oxidarlt stress hypothesis in parkinson's disease: evidence Supporting it.冱π11. Neur01.,32,804‑12.
81. Bains, J. S. and shaw, C. A. a997). Neurodegenerative disorders in humans: the role of glutathione in oxidative stress・mediated neuronal death.召raiπ Res Braiπ Res Rev.,25,335‑58.
82. Younes・Mhenni, S., Frih・Ayed, M., Kerkeni, A., Bost, M. atld chazot, G.(2007). peripheral blood markers ofoxidative stress in parkinson's disease.三Ur Neur0ι.58,78‑83.
83. Rommelfanger K. S., weinshenker, D.(2007). Norepinephrine: The redheaded stepchild of Parkinson's disease. Bioche111 Phar111αC01.,74,17フ‑90.
3土3早
84. LUO, S. X. and Huang, E. J.(2015). DopaminergiC 卜Jeurons and Brain Re、vard path、vays: From Neurogenesisto circU武 Assembly.冱1π. j path01., pii: SO002‑9440a5)00646・X.
85. B, Tharlvi. and T, LO.(2004). Long term motor complications of levodopa: clinical features, mechanisms, and managementstrategies. postgad. ued. j.,80,452‑458.
86. Dovero, S., Gross, C. arld Bezard, E.(2015). unexpected toxicity of very lo、v dose MPTp in mice: A clue to the aeti0108y ofparkinson's disease? syπαPse., doi:10.1002/syn21875.
87. Jackson・Lewis, V. a11d przedborski, S.(2007). protocol for the N伊Tp model ofparkinson'S disease.Ⅳ'at. protoc.,2,141‑151.
88. Abou・sleiman, P. M., Muqit, M. M. and wood, N.W.(2006). Expa11ding insights of mitochondrial dysfunction in parkinson's disease.Ⅳ'at. Rev.Ⅳ'eurosci.,フ,207‑219.
89. zorov, D. B., Juhaszova, M. and s0Ⅱott, S. J.(2014). Mitochondrial reactive oxygen species (ROS) and ROS・induced Ros release. physl'0IRev.,94,909‑50.
90. Himeda, T., Kadoguchi, N., Kamiyama, Y., Kato, H., Maegawa, H. and Araki, T.(2006).
Neuroprotective effect of arundic acid, an astrocyte・modulating agent, in mouse brain a8ainst 入4PTP (1・methyl・4・phenyl‑1,2,3,6・tetrahydropyridine) neurotoxicity.Ⅳ'europhar111ac010幻,.,50,
329‑44.
91. claustre, Y., Leone廿i, M., santucci, V., Bougault,1., Desvignes, C., Rouquier, L., Aubin, N., Keane, P., Busch, S., chen, Y., palejwala, V., Tocci, M., Yamdagni, P., Didier, M., Avenet, P., Le Fur, G., OUW・Donat, F., sca杜on, B. and steinberg, R.(2008). Effects of the beta3・adrenoceptor (Adrb3) agonist sR58611A (amibegron) on serotonergic a11d noradrenergic transmission in the rodent: relevance to its antidepressanvarlxiolytic・1ike profile. Neuroscie11Ce.,
156,353‑64.
92. Tanyeri, P., Buyukokuroglu, M. E., MUUU,0., ulak, G., Akar, F. Y., celikyurt,1. K. arld Erden, B. F.(20B). Evidence that the anxiolytic・1ike effects of the beta3 receptor agonist amibegron
involve serotoninergic receptor activity phar111αC01. Bioche111. Behαν.,110,27‑32.
91. Tanyeri, P., Buyukokuroglu, M. E., MUUU,0., ulak, G., Y11dlz Akar, F., Komsuoglu celikyurt.1.
and Erden, B. F.(2013).1nvolvement of serotonin receptor subtypes in the antidepressant・1ike effect of beta receptor agonist Amibegron (SR 58611A): an experimental study. pharJ11ac01 召ioche1ア1. Behαν.,105,12‑6.
92. TambureⅡa, A., Micale, V., Leggio, G.M. and Drago, F.(2010). The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress・induced behavioral and neurochemical changes. Eur.
Neuropsychopharmac01.,20,704・B.
93. Ropert, N., Jalil, A. a11d Li, D.(2015). Expression a11d ce11Ular function ofvsNARE proteins in brain astrocytes. Neuroscie11Ce., pii: S0306‑4522(15)00955・0.
94. Jahn, H.M., sche11er, A. and Kirchhoff, F.(2015). Genetic contr010fastrocyte function in neural Circuits. Fr011t ce11Neurosci.,9,310.
95. zer11n ト、1., LeV玲on s 、v and Goldman J.E i1995' Earl" pattcr;)s ofm1んratlon mor‑h0んenesls and inte柳ediate 丘lament expression ofsubventricular zone ceⅡS in the postnatalrat forebrain. j
<leurosci,.15,7238.49.
96. XU, C., Funahashi, Y.,圦,'atanabe, T., Takano, T., Nakamuta, S., Namba, T., Kaibuchi, K.,(2015).
Radial Glial ceⅡ・Neuron lnteraction Directs Axon Formation atthe opposite side ofthe Neuron from the contact site. j Neurosci.,35,1451732.
97. GuiⅡem, A. M., Martinez・Lozada, Z., Hemandez・KeⅡy, L. C., L6Pez・Bayghen, E., L6Pez・Bayghen, B., caⅡeros,0.A., campuzano, M. R. and odega, A.(2015). Methylphenidate Increases Glutamate uptake in Bergmarm Glial ceⅡS. Neurochem. Res.,40,2317‑24.
98. XU, C., Funahashi, Y., watanabe, T., Takano, T., Nakamuta, S., Namba, T. arld Kaibuchi, K.
(2015). Radial Glial ceⅡ・Neuron lnteraction Directs Axon Formation atthe opposite side ofthe Neuron from the contact site. j Neurosci.,35,14517‑32.
99. Goldstein, D. S.(2006). L・Dihydroxyphenylserine (L・DOPS): a norepinephrine prodrug.
Cardi0ναSC DrugRev.,24,189‑203.
100. Fukada, K., Endo, T., Yokoe, M., Hamasaki, T., Hazama, T. and sakoda, S.(2013).
L・threo‑3,4・dihydroxyphenylserine (L・DOPS) CO・administered with entacapone improves freezing ofgaitin parkinson's disease. uedHypotheses.,80,209・12.
101. Tong, J., Homykiewicz,0. and Kish, S.J.(2006).1nverse relationshゆ beNeen brain noradrenaline level and dopamine loss in parkinson disease: a possible neuroprotective role for noradrenaline.冱rch Ne1ιr01.,63,1724‑8.
i
102. Adori, C., Gluck, L., Barde, S., Yoshitake, T., Kovacs, G. G., Mulder, J., Mag16Czky, Z., Havas, L., B61Cskei, K., Mitsios, N., uhlen, M., Szolcsanyi, J., Kehr, J., Rδlmback, A., sch、vartz, T., Rehfeld, J. F., Harkany, T., palkovits, M., schulz, S. arld H6kfelt, T.(2015). critical role of Somatostatin receptor 2 in the vulnerability of the central noradrenergic system: ne、N aspects on
69
Alzheimer's disease.豆CtαⅣ'europath01.,129,541‑63.
103. parnphlett, R. and Kum Je、N, S.(2015). Different populations of Human Locus ceruleus Neurons contain HeaⅥ,, Metals or Hyperphosphorylated Tau:1mplications for Amyloid・β and Tau path010gy in Alzheimer'S Disease. j 豆IzheiJア1ers Dis.,45,437・47.
104. puertas MCI, Martinez・MaHOS JM, cobo MP, canera MP, Mayas MD, Ramirez,EXP6Sito MJ.
(2012). plasma oxidative stress parameters in men and 、Nomen with early stage Alzheimer type dementia.三χP Geroht01.,47,625‑30.
105. sgrensen, L.,1gel, C., Liv Hansen, N., osler, M., Lauritzen, M., Rostrup, E. and Nielsen, M.
(2015). Early detection of Alzheimer's disease using MN hゆPocampaltexture. HU111 Brα加 Uapp.,
106. cortical conelates ofaa'ective syndrome in dementia due to Hayata TT, Bergo FP, Rezende TJ, Damasceno A, Damasceno BP, cendes F, steⅡa F, Balthazar ML.(2015). Alzheimer's disease.
筏rq 入セ1ιropsl'qul'ail'.,73,553‑60.
107. Taga、va, R., Hashimoto, H., Matsuda, Y., uchida, K., Yoshida, A., Higashiyama, S., Ka、Nabe, J., Toshihiro, K., shiomi, S., Morl, H. and lnoue, K.(2014). conelation between right medial tempora110be atrophy and persecutory delusions in patients with dementia of the Alzheimer'S type demonstrated on vsRAD advance. osaka ciり, ued. j.,201460,73‑80.
108. paquet, C., Amin, J., Mouton・Liger, F., Nasser, M., Love, S., Gray, F., pickering, R. M., Nic0Ⅱ, J. A., Holmes, C., Hugon, J. and Boche, D.(2015). Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease. j path01.,235,721‑30.
109. shoji, M.(2014). Alzheimer's disease: a type ofcerebra1 血yloidosis. Bra加Ⅳ'erve.,66,837‑47.